| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADAPY (ADAPY) has 4 insiders with recent SEC Form 4 filings, including 19 buys and 1 sell. ADAPY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 100.37M | $3.41M | - | |
| COO | 986.4K | $33.5K | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2018 | Barrett M James | 10% Owner | Buy | 1,268,508 | $1.91 | $2,417,846.92 | +0.6% | |
| Mar 23, 2018 | Viswanathan Ravi | 10% Owner | Buy | 1,268,508 | $1.91 | $2,417,846.92 | +0.6% | |
| Mar 23, 2018 | Mott David M88 | Director, 10% Owner | Buy | 1,268,508 | $1.91 | $2,417,846.92 | +0.6% | |
| Mar 23, 2018 | Sonsini Peter W. | 10% Owner | Buy | 1,268,508 | $1.91 | $2,417,846.92 | +0.6% | |
| Mar 23, 2018 | Sandell Scott D55 | 10% Owner | Buy | 1,268,508 | $1.91 | $2,417,846.92 | +0.6% | |
| Mar 20, 2018 | Rawcliffe Adrian | Chief Financial Officer | Sell | 600,000 | $1.71 | $1,026,000.00 | -100% | |
| Mar 27, 2017 | Sandell Scott D55 | 10% Owner | Buy | 12,870,000 | $0.70 | $9,009,000.00 | +21.7% | |
| Mar 27, 2017 | Mott David M88 | Director, 10% Owner | Buy | 12,870,000 | $0.70 | $9,009,000.00 | +21.7% | |
| Mar 27, 2017 | Viswanathan Ravi | 10% Owner | Buy | 12,870,000 | $0.70 | $9,009,000.00 | +21.7% | |
| Mar 27, 2017 | Orbimed Advisors LLC67 | Director | Buy | 1,190,476 | $4.20 | $4,999,999.20 | +24.0% |